The pharmaceutical giant has won approval to build a manufacturing facility off Hulley Road at its Hurdsfield complex in Macclesfield, subject to resolving concerns over possible site contamination.
The proposed two-storey building is intended to enable AstraZeneca to hire 72 employees to join its 1,800 staff already based at the site. The scheme is part of the wider masterplan for Hurdsfield Industrial Estate, identified as a key employment site in the Cheshire East Local Plan.
Work will be able to start on the project subject to the discharging of a condition related to site remediation.
“The site was previously used for waste disposal and presents a high risk of contamination that could be mobilised during construction,” a report from Cheshire East Council said.
“Given the risks, the local planning authority is not able to grant planning permission for this application until the extent of contamination is known and the remediation strategy agreed.”
A spokesperson for AstraZeneca said: “As with any historic industrial site, we are following the normal processes to sample and remediate any historic ground contamination, if present.
“This is standard procedure. We requested a five-year period for planning permission to provide us with maximum flexibility in the current climate.”
Baker Hicks, part of construction giant Morgan Sindall Group, designed the scheme. Frost Planning is the planning consultant.